These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38714473)

  • 21. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
    Samsami-Kor M; Daryani NE; Asl PR; Hekmatdoost A
    Arch Med Res; 2015 May; 46(4):280-5. PubMed ID: 26002728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study.
    Huynh HQ; deBruyn J; Guan L; Diaz H; Li M; Girgis S; Turner J; Fedorak R; Madsen K
    Inflamm Bowel Dis; 2009 May; 15(5):760-8. PubMed ID: 19067432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis.
    Morshedzadeh N; Shahrokh S; Aghdaei HA; Amin Pourhoseingholi M; Chaleshi V; Hekmatdoost A; Karimi S; Zali MR; Mirmiran P
    Complement Ther Med; 2019 Oct; 46():36-43. PubMed ID: 31519285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index--a pilot study.
    Grimstad T; Berge RK; Bohov P; Skorve J; Gøransson L; Omdal R; Aasprong OG; Haugen M; Meltzer HM; Hausken T
    Scand J Clin Lab Invest; 2011 Feb; 71(1):68-73. PubMed ID: 21142420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Lactocare® Synbiotic on Disease Severity in Ulcerative Colitis: A Randomized Placebo-Controlled Double-Blind Clinical Trial.
    Amiriani T; Rajabli N; Faghani M; Besharat S; Roshandel G; Akhavan Tabib A; Joshaghani H
    Middle East J Dig Dis; 2020 Jan; 12(1):27-33. PubMed ID: 32082518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis.
    Zheng K; Zhang S; Wang C; Zhao W; Shen H
    PLoS One; 2015; 10(4):e0124211. PubMed ID: 25915777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis.
    Fritsch J; Garces L; Quintero MA; Pignac-Kobinger J; Santander AM; Fernández I; Ban YJ; Kwon D; Phillips MC; Knight K; Mao Q; Santaolalla R; Chen XS; Maruthamuthu M; Solis N; Damas OM; Kerman DH; Deshpande AR; Lewis JE; Chen C; Abreu MT
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1189-1199.e30. PubMed ID: 32445952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR
    Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
    Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.
    Naseri K; Dabiri H; Rostami-Nejad M; Yadegar A; Houri H; Olfatifar M; Sadeghi A; Saadati S; Ciacci C; Iovino P; Zali MR
    BMC Gastroenterol; 2021 Jul; 21(1):292. PubMed ID: 34261437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?
    Croft A; Lord A; Radford-Smith G
    J Crohns Colitis; 2022 Aug; 16(7):1089-1096. PubMed ID: 35147694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D Status and Its Relation to Inflammatory Markers in Patients with Mild to Moderate Ulcerative Colitis.
    Sharifi A; Nedjat S; Vahedi H; Veghari G; Hosseinzadeh-Attar MJ
    Middle East J Dig Dis; 2018 Apr; 10(2):84-89. PubMed ID: 30013756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a novel diet in attenuation of clinical activity of disease in patients with ulcerative colitis: a randomized, clinical trial.
    Narimani B; Sadeghi A; Daryani NE; Shahrokh S; Nilghaz M; Ghods M; Shafiee M; Shahparvari MR; Hekmatdoost A
    Sci Rep; 2024 Jun; 14(1):13791. PubMed ID: 38877032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial.
    Masnadi Shirazi K; Sotoudeh S; Masnadi Shirazi A; Moaddab SY; Nourpanah Z; Nikniaz Z
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101532. PubMed ID: 33067169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.
    de Bièvre MA; Vrij AA; Schoon EJ; Dijkstra G; de Jong AE; Oberndorff-Klein Woolthuis AH; Hemker HC; Stockbrügger RW
    Inflamm Bowel Dis; 2007 Jun; 13(6):753-8. PubMed ID: 17260365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Shimoyama T; Yamamoto T; Yoshiyama S; Nishikawa R; Umegae S
    Inflamm Bowel Dis; 2023 Sep; 29(9):1399-1408. PubMed ID: 36334015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.